Create an Account

Global Oncology Academy

Study Shows Importance of Comprehensive Genomic Profiling for NSCLC

ReachMD Healthcare Image
RestartResume

What do we need to know about comprehensive genomic profiling and CGP-directed therapies for NSCLC patients?

  • Overview

    This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

    Welcome to the new
    Global Oncology Academy website.

    NEW FEATURES:

    • Check out all the new educational programs we have added.New educational programs
    • Now mobile-friendly and easier to navigate.Now mobile-friendly
    • A learner profile that stores your history/CME certificates.Track your credits
    Register

    We’re glad to see you’re enjoying Global Oncology Academy…
    but how about a more personalized experience?

    Register for free
    You are now leaving Global Oncology Academy and going to a site run by another organization.

    Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.